Daniel N. Rodrigues-Nava

Downs Road
London, ENG SM25PT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

Deep and sustained radiological response after MEK-RAF inhibition in HRAS mutant apocrine carcinoma of the scalp.

Deep and sustained radiological response after MEK-RAF inhibition in HRAS mutant apocrine carcinoma of the scalp.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 04, 2019

Unilateral Isometric Squat: Test Reliability, Interlimb Asymmetries, and Relationships With Limb Dominance.

Unilateral Isometric Squat: Test Reliability, Interlimb Asymmetries, and Relationships With Limb Dominance.

Journal: Journal of strength and conditioning research

Published: February 12, 2019

Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer.

Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer.

Journal: The Journal of clinical investigation

Published: November 02, 2018

Family study of a novel mutation of mucopolysaccharidosis type VI with a severe phenotype and good response to enzymatic replacement therapy: Case report.

Family study of a novel mutation of mucopolysaccharidosis type VI with a severe phenotype and good response to enzymatic replacement therapy: Case report.

Journal: Medicine

Published: October 19, 2018

Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency.

Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency.

Journal: European urology

Published: July 20, 2018

Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer.

Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer.

Journal: The Journal of clinical investigation

Published: July 10, 2018

RB1 Heterogeneity in Advanced Metastatic Castration-Resistant Prostate Cancer.

RB1 Heterogeneity in Advanced Metastatic Castration-Resistant Prostate Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 29, 2018

Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer.

Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer.

Journal: The Journal of clinical investigation

Published: June 12, 2018

Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression.

Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression.

Journal: Molecular cell

Published: April 26, 2018

SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity.

SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 29, 2018

Ataxia Telangiectasia Mutated Protein Loss and Benefit From Oxaliplatin-based Chemotherapy in Colorectal Cancer.

Ataxia Telangiectasia Mutated Protein Loss and Benefit From Oxaliplatin-based Chemotherapy in Colorectal Cancer.

Journal: Clinical colorectal cancer

Published: March 29, 2018

Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss.

Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 28, 2018

Showing 1-12 of 66

Last Updated: 09/26/2026